US EditionRwanda's Vaccine Production, Economic Inclusion Get €95 Million Boost From EU
The €95 million EU investment supports Rwanda’s goal to become a regional vaccine hub and advance biotech innovation, building on BioNTech’s first African manufacturing plant.
5 Articles
5 Articles
Rwanda's Vaccine Production, Economic Inclusion Get €95 Million Boost From EU
Rwanda's efforts to advance vaccine production, economic inclusion, and medical innovation have received a major boost after the European Union (EU) committed a new €95 million (over Rwf 160 billion) investment to support the initiatives.
EU Grants Rwanda €95 Million to Boost BioNTech Vaccine Plant
PDF Button The European Union has granted Rwanda €95 million (about Rwf 160 billion) to support the BioNTech mRNA vaccine manufacturing plant in Kigali, in a move expected to strengthen Africa’s efforts toward vaccine independence and medical innovation. The funding announcement followed a meeting between President Paul Kagame and European Commission President Ursula von der […] Related Posts: HM King Mohammed VI Addresses Speech to 1st China-…
President Paul Kagame and the President of the European Commission, Ursula von der Leyen, have signed a €95 million partnership agreement to support healthcare in Rwanda. The funds will support the BioNTech mRNA vaccine manufacturing facility in Kigali. The President of the European Commission, Ursula von der Leyen, expressed her satisfaction with the reconciliation process between Rwanda and Congo, facilitated by US President Donald Trump. She …
Rwanda’s vaccine production, economic inclusion get €95 million boost from EU
Rwanda’s efforts to advance vaccine production, economic inclusion, and medical innovation have received a major boost after the European Union (EU) committed a new €95 million (over Rwf 160 billion) investment to support the initiatives. ALSO READ: Rwanda unveils BioNTech’s first vaccine manufacturing plant in Africa The funding was announced on Thursday, October 9, by Ursula von der Leyen, President of the European Commission, following a meet…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
